Related Experiment Video
Updated: Aug 7, 2026

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
Published on: August 21, 2013
Activation of the human FP prostanoid receptor disrupts mitosis progression and generates aneuploidy and polyploidy
1Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona 85721-0207, USA.
Abstract:
Studies have shown prostaglandin F(2alpha) (PGF(2alpha)) to be an endogenous tumor promoter in mouse models of skin carcinogenesis; however, the mechanisms by which PGF(2alpha) affects cell cycle events remain unknown. Here we performed cell cycle analyses on HEK cells stably expressing the human FP receptor and found that treatment with PGF(2alpha) delays mitosis and is associated with an increased expression of cyclin B1 and Cdc2 kinase activity. In addition, multipolar spindles and misaligned chromosomes were observed in a significant proportion of cells treated with PGF(2alpha). Defective cytokinesis was also observed which resulted in gross aneuploidy and polyploidy. Expression of dominant negative Rho attenuated the cell cycle delay and prevented the generation of micronuclei following treatment with PGF(2alpha). This suggests that FP receptor activation of Rho signaling by PGF(2alpha) can interfere with nuclear division. Aneuploidy is associated with genomic instability and may underlie the tumor-promoting properties of PGF(2alpha).
Insights
Prostaglandin F(2alpha) (PGF(2alpha)) delays mitosis and causes genomic instability by interfering with nuclear division via Rho signaling. This may explain its tumor-promoting effects in skin carcinogenesis.
Area of Science:
- Cell Biology
- Cancer Research
- Molecular Biology
Background:
- Prostaglandin F(2alpha) (PGF(2alpha)) is an endogenous tumor promoter in skin carcinogenesis models.
- The precise mechanisms by which PGF(2alpha) influences cell cycle progression are not fully understood.
Purpose of the Study:
- To investigate the effects of PGF(2alpha) on cell cycle events in HEK cells expressing the human FP receptor.
- To elucidate the molecular pathways involved in PGF(2alpha)-mediated cell cycle disruption.
Main Methods:
- Cell cycle analysis of HEK cells treated with PGF(2alpha).
- Assessment of cyclin B1 expression and Cdc2 kinase activity.
- Microscopic observation of spindle formation and chromosome alignment.
- Evaluation of cytokinesis and ploidy.
- Analysis of Rho signaling pathway involvement using dominant-negative Rho.
Main Results:
- PGF(2alpha) treatment delayed mitosis and increased cyclin B1 expression and Cdc2 kinase activity.
- Observed were multipolar spindles, misaligned chromosomes, and defective cytokinesis, leading to aneuploidy and polyploidy.
- Inhibition of Rho signaling attenuated PGF(2alpha)-induced cell cycle delay and prevented micronuclei formation.
Conclusions:
- PGF(2alpha) activates Rho signaling through the FP receptor, interfering with nuclear division.
- The resulting aneuploidy and genomic instability may contribute to the tumor-promoting properties of PGF(2alpha).
Related Concept Videos
Negative Regulator Molecules
Nondisjunction
Mitogens and the Cell Cycle
Abnormal Proliferation
Nondisjunction
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

